Showing results (1781-1790 of 1,979) with videos related to

Sort By:
Pageof 198
Annals of Surgical Oncology|October 31, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Bicuspid Aortic Valve Disease With Early Onset Complications: Characteristics And Aortic OutcomesMaximilian A Selbst, Megan K Laughlin, Colin R Ward, et al.
Frontiers in Immunology|September 25, 2023
Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1Marta Sanz, Ann Marie K Weideman, Adam R Ward, et al.
JCI Insight|January 5, 2021
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapyEva M Stevenson, Adam R Ward, Ronald Truong, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Annals of Surgery|October 16, 2020
Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma TrialsJohn B Holcomb, Ernest E Moore, Jason L Sperry, et al.
Canadian Journal of Microbiology|January 18, 2026
Surveillance of live birds for active and past infections reveals the impact of highly pathogenic H5N1 on seabird populations in Atlantic CanadaIshraq Rahman, Jordan Wight, Joshua T Cunningham, et al.
Cell Reports|May 7, 2025
EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypesAndrea Gramatica, Itzayana G Miller, Adam R Ward, et al.
Molecular Therapy. Advances|May 15, 2026
Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophyGretchen Thomsen, Allan Kaspar, Laura Ferraiuolo, et al.
Pageof 198